Five Prime Therapeutics to Present at BIO CEO

Five Prime Therapeutics to Present at BIO CEO

SOUTH SAN FRANCISCO, Calif., Feb. 3, 2014 (GLOBE NEWSWIRE) -- Five Prime
Therapeutics, Inc. (Nasdaq:FPRX), a clinical-stage biotechnology company
focused on discovering and developing novel protein therapeutics for cancer
and inflammatory diseases, today announced that Lewis T. "Rusty" Williams,
M.D., Ph.D., President and Chief Executive Officer of Five Prime, will present
at the 16^th Annual BIO CEO & Investor Conference on Monday, February 10, at 2
p.m. Eastern Time. The conference will take place at the Waldorf Astoria Hotel
in New York City.

The live webcast will be accessible at
http://investor.fiveprime.com/events.cfm or as a direct feed from
http://www.veracast.com/webcasts/bio/ceoinvestor2014/69136447092.cfm. Five
Prime will maintain an archived replay of the webcast on its website for 30
days after the conference.

About Five Prime

Five Prime is a clinical-stage biotechnology company focused on discovering
and developing novel protein therapeutics for cancer and inflammatory
diseases. Five Prime has developed a library of more than 5,700 human
extracellular proteins. Five Prime screens this comprehensive library with its
proprietary high-throughput protein screening technologies to identify new
targets for protein therapeutics. Additional information can be found at the
company's website: www.fiveprime.com.

CONTACT: COMPANY CONTACT:
        
         Amy Kendall
         Corporate Communications
         415-365-5776
         amy.kendall@fiveprime.com

Five Prime Therapeutics, Inc. Logo
 
Press spacebar to pause and continue. Press esc to stop.